WASHINGTON — A broad tariff on imported pharmaceuticals took effect at the end of September, and some biopharma companies and ...

TRex Bio and Retension Pharmaceuticals are set to continue the industry’s public debut rebound.

A year after a bearish market led to a year-over-year decline in the market capitalization (the product of the share price and the number of outstanding shares) of the top 25 public biotechnology ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

IBB has delivered stronger returns than IYH but with dramatically sharper swings in both directions. Here is how to decide which trade-off fits your portfolio.

The bulk of coverage towards the top gaining stock sectors over the past year has focused understandably on technology, which has made huge strides, with semiconductors exceeding +60%. However, the ...

INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...

Stanford neuroscientist Andrew Huberman predicts Meta Platforms Inc. META, OpenAI and Anthropic could eventually become ...

The biotech company is downsizing to fund another trial after a drug showed no meaningful benefit. The move comes just a year after its IPO.

Fitó, a family-owned plant breeding company, and Hudson River Biotechnology, a technology company specializing in plant ...